|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-0.39/0.35
|
企业价值
245.61M
|
资产负债 |
每股账面净值
0.48
|
现金流量 |
现金流量率
--
|
损益表 |
收益
0
|
每股收益
--
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/05/20 09:39 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
"HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram (""ECG"") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography (""VECG"") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration (""FDA"") clearance for its initial telehealth products." |